Jian Lin

Nanjing Agricultural University

H指数:41

被引数:4,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Engineered Bacillus subtilis to deliver dsRNA via extracellular vesicles against the H9N2 avian influenza virus

工程化枯草芽孢杆菌通过外泌体递送dsRNA以对抗H9N2禽流感病毒

Trends in Biotechnology

IF14.9

2026-06-190

OAAI

Comparative Analysis of Isavuconazole DDIs With Other Azole Antifungal Drugs and PBPK Model-Informed Dosing Recommendations for Anticancer Drugs

伊曲康唑DDIs与其他唑类抗真菌药物的对比分析及基于PBPK模型的抗癌药物剂量推荐

CPT: Pharmacometrics & Systems Pharmacology

IF0

2025-10-170

OAAI

Correction: A double-edged sword in antiviral defence: ATG7 binding dicer to promote virus replication

更正：抗病毒防御中的双刃剑：ATG7结合Dicer以促进病毒复制

Cellular and Molecular Life Sciences

IF6.2

2025-07-120

Trained immunity using probiotics and inactivated pathogens enhances resistance to Salmonella enterica serovar Typhimurium infection by activating the cGAS-STING signal pathway in mice and chickens

使用益生菌和灭活病原体诱导的 trained immunity 通过激活 cGAS-STING 信号通路，增强了小鼠和鸡对 Salmonella enterica serovar Typhimurium 感染的抵抗力。

Journal of Advanced Research

IF13

2025-03-120

OAAI

A double-edged sword in antiviral defence: ATG7 binding dicer to promote virus replication

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2025-02-220

OAAI

Virus-derived siRNA: Coronavirus and influenza virus trigger antiviral RNAi immunity in birds

病毒源性siRNA：冠状病毒和流感病毒在鸟类中触发抗病毒RNAi免疫

NUCLEIC ACIDS RESEARCH

IF13.1

2025-02-201

Prediction of Drug-Drug Interactions for Highly Plasma Protein Bound Compounds

预测高血浆蛋白结合化合物的药物-药物相互作用

AAPS JOURNAL

IF3.7

2024-12-120

PRE

from Bacillus subtilis enhances immune response and contributes to the maintenance of intestinal microbial homeostasis

MICROBIOLOGY SPECTRUM

IF3.8

2024-12-054

OAAI

Metabolomic profiling reveals new insights into human adenovirus type 7 infection

MICROBIAL PATHOGENESIS

IF3.5

2024-12-010

PRE

Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage Form

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-05-262

OAAI

PBPK Modeling of PAXLOVID™: Incorporating Rotamer Conversion Kinetics to Advanced Dissolution and Absorption Model

PAXLOVID的PBPK建模™: 将旋转异构体转化动力学纳入高级溶出和吸收模型

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2024-01-011

PRE

Study of the ketohexokinase inhibitor PF-06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2023-12-180

OAAI

Physiologically-Based Pharmacokinetic Modeling of PAXLOVID™ with First-Order Absorption Kinetics

PHARMACEUTICAL RESEARCH

IF4.3

2023-05-2511

OAAI

IBV QX affects the antigen presentation function of BMDCs through nonstructural protein16

POULTRY SCIENCE

IF4.2

2023-05-012

OAAI

Effect of Hepatic Impairment on OATP1B Activity: Quantitative Pharmacokinetic Analysis of Endogenous Biomarker and Substrate Drugs

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2023-01-1521

PRE

Investigation of CYP3A induction by PF-05251749 in early clinical development: comparison of linear slope physiologically based pharmacokinetic prediction and biomarker response

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2022-07-025

OAAI

From nasal to basal: single-cell sequencing of the bursa of Fabricius highlights the IBDV infection mechanism in chickens

CELL AND BIOSCIENCE

IF6.2

2021-12-1624

OAAI

Large-scale genome-wide study reveals climate adaptive variability in a cosmopolitan pest

大规模全基因组研究揭示了世界性害虫的气候适应性变异

NATURE COMMUNICATIONS

IF15.7

2021-12-1033

OAAI

Bacillus subtilis Spore-Trained Dendritic Cells Enhance the Generation of Memory T Cells via ICAM1

CELLS

IF5.2

2021-08-316

OAAI

Quantitative prediction of breast cancer resistant protein mediated drug-drug interactions using physiologically-based pharmacokinetic modeling

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2021-07-2037

OAAI

Jian Lin

个人简介

教育背景

工作经历

荣誉奖项

研究方向